This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma.
European journal of nuclear medicine and molecular imaging, 46(3), 614-622
Citation
Królicki, Leszek; Bruchertseifer, Frank; Kunikowska, Jolanta; Koziara, Henryk; Królicki, Bartosz; Jakuciński, Maciej; Pawlak, Dariusz; Apostolidis, Christos; Mirzadeh, Saed; Rola, Rafał; Merlo, Adrian; Morgenstern, Alfred. (2019). Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma.. European journal of nuclear medicine and molecular imaging, 46(3), 614-622. https://doi.org/10.1007/s00259-018-4225-7